row_id,series_id,timepoint_h,organism,strain_id,drug_name,target_gene,mutation_id,mutant_frac_target_mod,mic_drug_mg_L,resistant_mic_cutoff_mg_L,media,assay_method,source_type,penetration_signal,earliest_penetration,notes
ABXRM005-TR-0001,S1,0,Staphylococcus aureus,SA-CLIN101,rifampicin,rpoB,rpoB_S531L,0.00,0.03,1.00,CAMHB,amplicon_seq,simulated,0,0,baseline
ABXRM005-TR-0002,S1,12,Staphylococcus aureus,SA-CLIN101,rifampicin,rpoB,rpoB_S531L,0.05,0.03,1.00,CAMHB,amplicon_seq,simulated,0,0,early low level
ABXRM005-TR-0003,S1,24,Staphylococcus aureus,SA-CLIN101,rifampicin,rpoB,rpoB_S531L,0.22,0.06,1.00,CAMHB,amplicon_seq,simulated,1,1,penetration before phenotype
ABXRM005-TR-0004,S1,48,Staphylococcus aureus,SA-CLIN101,rifampicin,rpoB,rpoB_S531L,0.55,4.00,1.00,CAMHB,amplicon_seq,simulated,1,0,phenotype emerges
ABXRM005-TR-0005,S2,0,Escherichia coli,EC-CLIN220,ciprofloxacin,gyrA,gyrA_S83L,0.00,0.25,1.00,CAMHB,amplicon_seq,simulated,0,0,baseline
ABXRM005-TR-0006,S2,24,Escherichia coli,EC-CLIN220,ciprofloxacin,gyrA,gyrA_S83L,0.04,0.25,1.00,CAMHB,amplicon_seq,simulated,0,0,stable
ABXRM005-TR-0007,S2,48,Escherichia coli,EC-CLIN220,ciprofloxacin,gyrA,gyrA_S83L,0.06,0.25,1.00,CAMHB,amplicon_seq,simulated,0,0,no penetration
ABXRM005-TR-0008,S3,0,Streptococcus pneumoniae,SP-CLIN330,penicillin,pbp2x,pbp2x_T338A,0.00,0.06,2.00,CAMHB,amplicon_seq,simulated,0,0,baseline
ABXRM005-TR-0009,S3,12,Streptococcus pneumoniae,SP-CLIN330,penicillin,pbp2x,pbp2x_T338A,0.85,0.06,2.00,CAMHB,amplicon_seq,simulated,0,0,spike candidate
ABXRM005-TR-0010,S3,24,Streptococcus pneumoniae,SP-CLIN330,penicillin,pbp2x,pbp2x_T338A,0.02,0.06,2.00,CAMHB,amplicon_seq,simulated,0,0,snapback artifact